A detailed history of Hudson Portfolio Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hudson Portfolio Management LLC holds 2,335 shares of ABBV stock, worth $418,432. This represents 0.46% of its overall portfolio holdings.

Number of Shares
2,335
Previous 3,600 35.14%
Holding current value
$418,432
Previous $557,000 17.24%
% of portfolio
0.46%
Previous 0.61%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $207,257 - $252,152
-1,265 Reduced 35.14%
2,335 $461,000
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $20,640 - $23,245
-150 Reduced 4.0%
3,600 $557,000
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $125,884 - $156,655
-950 Reduced 20.21%
3,750 $505,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $153,286 - $176,532
-1,060 Reduced 18.4%
4,700 $749,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $288,376 - $345,838
-2,085 Reduced 26.58%
5,760 $931,000
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $46,973 - $53,875
-350 Reduced 4.27%
7,845 $1.05 Million
Q2 2022

Aug 09, 2022

SELL
$137.62 - $174.96 $395,657 - $503,010
-2,875 Reduced 25.97%
8,195 $1.26 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $745,687 - $925,187
-5,650 Reduced 33.79%
11,070 $1.8 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $16,114 - $20,389
-150 Reduced 0.89%
16,720 $2.26 Million
Q3 2021

Nov 09, 2021

SELL
$106.4 - $120.78 $10,640 - $12,078
-100 Reduced 0.59%
16,870 $1.82 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $1.74 Million - $1.91 Million
16,970 New
16,970 $1.84 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hudson Portfolio Management LLC Portfolio

Follow Hudson Portfolio Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Portfolio Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Portfolio Management LLC with notifications on news.